Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in ...
Fluxion Biosciences, a leading developer of microfluidic systems for functional cell analysis, today announced that it has received a $1.8 million NIH grant for the development of a high-throughput ...
SINGAPORE, Dec. 18, 2025 /PRNewswire/ -- Fluxion Network, Mantle's full-stack native decentralized exchange (DEX), has officially launched on its Mainnet, marking a major milestone in the network's ...
Fluxion Biosciences Expands IsoFlux Discovery Services Capabilities with Clinical Sample Procurement
Fluxion Biosciences, Inc. announced a new capability to include full-service clinical sample procurement that will expand Fluxion’s IsoFlux Discovery Services offering. Fluxion currently offers a ...
Fluxion Biosciences Launches New Range of Circulating Tumor Cell (CTC) Recovery Kits- First Launch of Commercial Kits Targeting EMT Cells New kits add additional markers to improve capture efficiency ...
Group will provide live-cell assays in response to increasing demand. Fluxion Biosciences is launching a discovery services business to support growing demand for assay support on Fluxion’s cell ...
Fluxion Biosciences has announced that it has signed a distribution agreement for EMD Millipore’s PrecisION® range of ion channel cell lines. The non-exclusive distribution agreement will combine ...
MANILA, Philippines – Xurpas Inc., the listed technology company, has acquired full ownership of mobile and internet systems developer Fluxion. In a disclosure to the Philippine Stock Exchange, Xurpas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results